News

Home / News

Announcement on behalf of major subsidiary, TOP PHARM. MEDICALWARE COMPANY LIMITED, regarding the release of non-competition restrictions for Directors

2026.5.15

1.Date of the shareholders' meeting resolution:2026/05/15

2.Name and title of the managerial officer with permission to engage in competitive conduct:Jui-Wen Wu;Director

3.Items of competitive conduct in which the officer is permitted to engage:Similiar scope of business of director of management

4.Period of permission to engage in the competitive conduct: The period of being director of the Company.

5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):
(1)6,769,924 in total voting rights were represented at the time of voting; (2)6,769,924 voting right presented for, 100% of total voting rights; (3)0 voting right presented against, 0% of total voting rights; (4)0 invalid votes, 0% of total voting rights; (5)0 voting right presented abstention and not voting,0% of total voting rights; (6)This proposal was approved as proposed as affirmative rights higher than statutory ones.
6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the directors (if it is not the operator of a mainland China enterprise, please enter “N/A” below):N/A

7.Company name of the mainland China enterprise and the officer’s position in the enterprise:N/A

8.Address of the mainland China enterprise:N/A

9.Operations of the mainland China enterprise:N/A

10.Impact on the company’s finance and business:N/A.

11.If the directors have invested in the mainland China enterprise, the monetary amount of the investment and their shareholding ratio:N/A

12.Any other matters that need to be specified:None.